Jordan Henry

expert panel

The healthcare industry’s relationship with Big Tech has entered a new phase. What once looked like experimentation has evolved into a sustained push into primary care, diagnostics, pharmacy, remote monitoring and consumer health. Amazon owns One Medical. Apple continues expanding the health capabilities of the Apple Watch. AI-powered healthcare tools are accelerating across nearly every corner of the patient experience. For healthcare leaders, it’s no longer about whether companies like Amazon and Apple will influence care delivery. It’s about determining where collaboration creates value, where competition becomes necessary and how providers can preserve the clinical trust and accountability that technology platforms still struggle to replicate. That tension is reshaping strategic priorities across the industry. According to an American Hospital Association analysis of Amazon’s One Medical expansion, Amazon is steadily expanding its healthcare footprint through employer partnerships, integrated pharmacy services and digitally driven care models designed around consumer convenience. At the same time, Apple’s growing portfolio of FDA-cleared health features continues raising patient expectations around personalization, accessibility and real-time health insights. Members of the Senior Executive Healthcare Think Tank—a group of leaders specializing in healthcare technology, patient experience, AI, policy, interoperability and digital transformation—say providers should resist viewing every Big Tech expansion as a direct threat. Instead, they argue healthcare organizations need a clearer framework for deciding which capabilities should be outsourced, which partnerships deserve investment and which parts of the patient relationship must remain firmly under provider control. Across the following perspectives, Think Tank members explore where the clearest competitive boundaries are emerging—from clinical governance and patient trust to interoperability, logistics and data ownership—and what healthcare executives should do now to avoid becoming interchangeable service providers within someone else’s platform ecosystem.

expert panel

Artificial intelligence is rapidly reshaping healthcare, from predictive analytics to clinical decision support. Yet its promise comes with a critical caveat: AI systems are only as reliable and equitable as the data and decisions that shape them. Without intentional oversight, these tools risk reinforcing—rather than reducing—longstanding disparities in care delivery. Members of the Senior Executive Healthcare Think Tank bring deep expertise across technology, policy, patient experience and equity. They believe addressing bias in clinical AI is not just a technical challenge but a leadership responsibility. A recent analysis from Kaiser Family Foundation found that AI can exacerbate disparities when models are trained on biased or incomplete data, with studies linking AI use to longer wait times, underdiagnosis and poorer predictive performance for Black and Hispanic patients. At the same time, the research notes that AI could help reduce disparities if it is intentionally designed with representative data, transparency and ongoing oversight—reinforcing the dual reality leaders now face. Against this backdrop, healthcare leaders must rethink how AI is designed, validated and governed. The following insights from Think Tank members offer a roadmap for ensuring clinical AI improves outcomes for all patients—not just a subset.

expert panel

Healthcare affordability remains one of the most persistent and complex challenges facing policymakers, providers and employers today. While coverage rates have improved in recent years, being insured does not always translate into affordable access. High deductibles, co-pays and other out-of-pocket expenses continue to create financial strain, particularly for lower-income and vulnerable populations who may technically have coverage but still struggle to use it. A Harvard analysis of rising health insurance premiums highlights how costs continue to increase for many Americans, particularly as enhanced subsidies expire, forcing more individuals to shoulder higher financial burdens. This dynamic not only limits access to timely care but also contributes to a cycle of delayed treatment and escalating healthcare spending. The challenge, then, is not simply reducing costs, but doing so in a way that improves access, maintains actuarial balance and avoids shifting financial burdens elsewhere. Insights from the Senior Executive Healthcare Think Tank—a curated group of leaders across patient experience, policy, workforce strategy and health technology—offer a nuanced view of how targeted reforms can do exactly that: deliver affordability where it is needed most without creating unintended consequences across the healthcare ecosystem.